Johnson & Johnson's Q3 earnings exceed expectations, driven by pharmaceutical sales but impacted by geopolitical issues and a sluggish medical devices market. Discover the company's strategies and ...

BioNTech's experimental mRNA cancer immunotherapy BNT113 did not meet its primary goal in a head and neck cancer trial, ...

Roche has entered a significant licensing deal with Rona Therapeutics for an obesity drug, marking its entry into a ...

Bengaluru-based Peptris Technologies secures ₹86 crore RDI support for the preclinical development of innovative ...

NuSynth Technologies, a Bengaluru-based startup, has raised ₹36.5 crore in seed funding to develop an AI-driven chemical ...

Zydus Lifesciences announces that the FDA has accepted the BLA for FYB206, a biosimilar to Keytruda. As the patent expiration ...

India’s effort to shield domestic manufacturers from low-cost Chinese imports has yet to deliver the desired gains. Speaking ...

Teva Pharmaceuticals has gained FDA approval for Weltruza, a monthly injectable treatment for schizophrenia, aiming to ...

Syndax Pharmaceuticals has announced the cessation of its treatment for idiopathic pulmonary fibrosis after a mid-stage trial ...

The Supreme Court of India has called for extensive drug price regulation beyond just cancer medications, questioning high ...

Bristol Myers Squibb's late-stage trial shows that a lower dose of admilparant significantly improves lung function in ...

The Indian government's new cap on trade margins for anti-cancer medications aims to enhance drug pricing transparency and ...